Management Team

Stephane crop

Stéphane Bédard, President, CEO and Chairman of the Board

Stéphane has more than 15 years of experience in the creation and management of high-tech companies. Former COO of Victhom Human Bionics Inc. (TSX:VHB), a medical device company that he founded in 1998, Mr. Bédard is recognized within the orthotic and prosthetic community as the inventor of the Power Knee™, the first motorized leg prosthesis for above-knee (AK) amputees.

Read more »

The Power Knee™ is seen as the new generation of AK prosthesis and has dramatically changed the way to design, to fit and to use a leg prosthesis.  Highlights from Stéphane resume are summarized below:

  • Founder of Victhom Human Bionics Inc.;
  • Inventor of the Power Knee™, the first motorized bionic leg prosthesis for AK amputees;
  • Chief Operating Officer of Victhom Human Bionics Inc.;
  • Over 15 years of experience as a senior manager (Maxivox Inc. and Victhom Inc.);
  • Electrical engineer, Masters in mechanical engineering and Doctoral studies in biomechatronics;
  • Author or co-author of approximately 90 patents in the field of biomechatronics and exercisers;
  • Strong scientific background in the field of robotics, automation and biomechatronics;
  • Principal investigator of numerous clinical trials for Class II medical devices;
  • Speaker at numerous international conferences and symposiums.
Pamela Borges

Pamela Borges, VP Market Access and External Affairs

Pamela is a market access, external affairs and communications strategist who has worked in the biopharmaceutical and medical device industry both in Canada and internationally for over 19 years.

Read more »

She has commercialized products across a broad range of therapeutic areas, including those in chronic and rare disorder categories. As a Canadian and global brand manager for Plavix®, she drove the global market development strategy, branding, and value story communication plan for the Top 6 markets, EU, Intercontinental and Asia Pacific regions. With the evolution of government and private sector regulatory changes in reimbursement, she has held leadership roles in multiple organizations to elevate the priority of patient access and the development of an integrated strategic approach with stakeholder engagement, health economics, real world data, pricing and contracting. Pamela has served as Chair of the Market Access Working Group at BIOTECanada and Co-Chair of Joint HTA Committee at Innovative Medicines Canada to lead industry efforts to advocate for efficient, consistent health technology assessment and pricing policies to support the value of the innovation for patients and society. In her various positions, she has been based in Toronto, Montreal and Paris. She holds a Bachelor of Science from the University of Toronto.

Nori Minicilli

Nori Minicilli, Director of Sales

Nori is pleased for the opportunity to grow with B-TEMIA Inc. since joining the company in April 2017.Coming from a strong healthcare business background and acumen with rigorous experience throughout North America, Nori brings more than eleven years of proven expertise within the medical device industry. Nori genuinely prides himself on guiding and tailoring unique business solutions to meet and exceed the expectations of his clients and team.

Read more »

Prior to his involvement with B-Temia Inc. and this emerging robust industry, Nori managed and grew a multi-million dollars annual book of business within the durable medical equipment industry in the United States for a privately held medical device distributor. Having worked in both the USA and Canada, highlights from Nori’s resume include growing territories within the medical device sector, executing fresh sales initiatives, and solidly defining and implementing comprehensive new business growth strategies.